Human Recombinant TACI (from HEK293)
Supplier: ACRO Biosystems
Certificates
About this item
Specifications
- Protein/Peptide Type:Recombinant
- Source:HEK293 cells
- Species:Human
- Storage Conditions:–20 °C
- Endotoxin Content:Less than 1.0 EU per μg by the LAL method.
- Biological Activity:Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.; Measured by its binding ability in a functional ELISA. Immobilized Human BAFF, Fc Tag (Cat. No. BAF-H4268) at 2 μg/mL (100 μL/well) can bind Biotinylated Human TACI, Fc,Avitag (Cat. No. TAI-H82F6) with a linear range of 1.2-39 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilized Human APRIL, Fc Tag (Cat. No. APL-H5267) at 5 μg/mL (100 μL/well) can bind Biotinylated Human TACI, Fc,Avitag (Cat. No. TAI-H82F6) with a linear range of 0.01-0.313 μg/mL (Routinely tested).
- Gene ID:O14836-1
- Carrier-Free:Y
- Protease-free:Y
- Animal-Free:Y
- Protein Synonyms:CD267|TNFRSF13B|TACI
- Protein/Peptide Name:TACI
- Purity:>90%
- Molecular Weight:46.7 kDa
- Endotoxin Level:Low
- Formulation:Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
- Nuclease-free:Y
- Shipping Temperature:Powder,RT
Specifications
Frequently Bought Together